Evidence map›Paper›PMID 39000063›Full record

ArticleInternational journal of molecular sciences2024

Deciphering the Interplay: Thieno[2,3-

Zdravko Odak, Sandra Marijan, Mila Radan, Lisa I Pilkington, Monika Čikeš Botić, David Barker, Jóhannes Reynisson, Euphemia Leung, Vedrana Čikeš Čulić

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Thieno[2,3-International journal of molecular sciences · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zdravko OdakDepartment of Gynecology and Obstetrics, University Hospital of Split, 21000 Split, Croatia.ORCID 0000-0001-8341-9760
Sandra MarijanDepartment of Medical Chemistry and Biochemistry, University of Split School of Medicine, 21000 Split, Croatia.ORCID 0000-0003-2259-2871
Mila RadanDepartment of Biochemistry, Faculty of Chemistry and Technology, University of Split, 21000 Split, Croatia.ORCID 0000-0001-7932-5817
Lisa I PilkingtonSchool of Chemical Sciences, The University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0002-9292-3261
Monika Čikeš BotićDepartment of Gynecology and Obstetrics, University Hospital of Split, 21000 Split, Croatia.ORCID 0000-0001-5821-6785
David BarkerSchool of Chemical Sciences, The University of Auckland, Auckland 1010, New Zealand.ORCID 0000-0002-3425-6552
Jóhannes ReynissonSchool of Pharmacy and Bioengineering, Keele University, Staffordshire ST5 5BG, UK.ORCID 0000-0003-4174-9512
Euphemia LeungFaculty of Medical and Health Sciences, Auckland Cancer Society Research Centre, Auckland 1010, New Zealand.ORCID 0000-0002-6932-3188
Vedrana Čikeš ČulićDepartment of Medical Chemistry and Biochemistry, University of Split School of Medicine, 21000 Split, Croatia.ORCID 0000-0002-4415-4410

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer is among the most prevalent causes of mortality among women. Despite improvements in diagnostic methods, non-specific symptoms and delayed gynecological exams can lead to late-stage ovarian tumor discovery. In this study, the effect of an anti-cancer compound, 3-amino-

Indexed as

ApoptosisGlycosphingolipidsMetabolomicsOvarian NeoplasmsAntineoplastic AgentsCell Line, TumorFemaleHumansMetabolomeNeoplastic Stem CellsPyridinesAntineoplastic AgentsGlycosphingolipidsPyridinesapoptosiscancer stem cells (CSCs)cytotoxicityglycosphingolipids (GSLs)metabolomicsovarian cancerthieno[2,3-b]pyridine

Identifiers

PMID39000063
PMCPMC11241605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.